Cognitive rehabilitation for schizophrenia and the putative role of motivation and expectancies.

Schizophrenia Bulletin
Dawn I VelliganJames M Gold

Abstract

Cognitive rehabilitation (CR) approaches seek to enhance cognitive processes or to circumvent cognitive impairments in schizophrenia in an effort to improve functional outcome. In this review we examine the research findings on the 8 evidence-based approaches to cognitive remediation listed in the 2005 Training Grid Outlining Best Practices for Recovery and Improved Outcomes for People With Serious Mental Illness, developed by the American Psychological Association Committee for the Advancement of Professional Practice. Though the approaches vary widely in theoretical orientation and methods of intervention, the results are, for the most part, encouraging. Improvements in attention, memory, and executive functioning have been reported. However, many persons with schizophrenia are more impaired in real-world functioning than one would expect given the magnitude of their cognitive deficits. We may need to look beyond cognition to other targets such as motivation to identify the reasons that many persons with schizophrenia demonstrate such marked levels of disability. Although a number of current CR approaches address motivation to varying degrees, treating motivation as a primary target may be needed to maximize CR outcomes.

References

Feb 1, 1992·Journal of Abnormal Psychology·H Berenbaum, T F Oltmanns
Dec 1, 1991·Journal of Behavior Therapy and Experimental Psychiatry·A A MendittoN C Beck
Jul 1, 1991·Archives of General Psychiatry·A J SaykinP Stafiniak
Jan 1, 1986·Schizophrenia Bulletin·W D SpauldingM Sullivan
Apr 1, 1987·Journal of Clinical and Experimental Neuropsychology·M M Sohlberg, C A Mateer
Aug 1, 1987·Psychological Medicine·H BerenbaumT F Oltmanns
Jan 1, 1980·Schizophrenia Bulletin·C J WallaceC Ferris
Jan 1, 1994·Acta Psychiatrica Scandinavica. Supplementum·B Hodel, H D Brenner
Feb 1, 1994·Archives of General Psychiatry·A J SaykinR C Gur
Feb 1, 1993·Psychological Medicine·A DelahuntyB Frost
Nov 1, 1993·Journal of Abnormal Psychology·A M KringJ M Neale
Jan 1, 1995·European Archives of Psychiatry and Clinical Neuroscience·R SchlenkerG Hopmann
Mar 1, 1996·The American Journal of Psychiatry·M F Green
Mar 14, 1997·Science·W SchultzP R Montague
May 3, 1997·Schizophrenia Research·D I VelliganA L Miller
Jan 1, 1995·Journal of the International Neuropsychological Society : JINS·J S PaulsenD V Jeste
Mar 21, 1998·Schizophrenia Bulletin·A MedaliaA E Merriam
Jul 23, 1998·Neuropsychology·R W Heinrichs, K K Zakzanis
Nov 6, 1998·Journal of Cognitive Neuroscience·D M EgelmanP R Montague
Dec 22, 1998·Brain Research. Brain Research Reviews·K C Berridge, T E Robinson
Mar 17, 1999·Psychological Medicine·R E O'CarrollE C Johnstone
Sep 10, 1999·Acta Psychiatrica Scandinavica·B R Rund, N E Borg
Feb 10, 2000·Schizophrenia Bulletin·W D SpauldingM Weiler
Nov 22, 2000·Schizophrenia Bulletin·I Myin-GermeysM W deVries
May 17, 2001·Schizophrenia Bulletin·A MedaliaM Casey
Nov 13, 2001·Clinical Psychology Review·T Wykes, M van der Gaag
Sep 12, 2002·Schizophrenia Research·Alice MedaliaMatthew Casey
Nov 2, 2002·The American Journal of Psychiatry·Robert S KernMichael F Green
Jan 25, 2003·Psychopharmacology·Lydia Krabbendam, André Aleman
Apr 16, 2003·Schizophrenia Bulletin·Dawn I VelliganAlbana Dassori
Jul 16, 2003·Psychiatry Research·Beatriz López-Luengo, Carmelo Vázquez
Aug 6, 2003·Trends in Neurosciences·Samuel M McClureP Read Montague

❮ Previous
Next ❯

Citations

May 16, 2009·Neuropsychology Review·Alice Medalia, Jimmy Choi
Jul 30, 2009·Neuropsychology Review·Barton W PalmerRobert K Heaton
Aug 16, 2011·Acta Pharmacologica Sinica·Jaqueline Nascimento PicadaPatrícia Pereira
Nov 30, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·William T Carpenter, James I Koenig
Feb 5, 2011·Neuropsychological Rehabilitation·Colette SeterShataya Worth
May 10, 2013·Psychotherapy Research : Journal of the Society for Psychotherapy Research·Sandrine PihetLaurent Holzer
Aug 15, 2006·Schizophrenia Bulletin·William Spaulding, Jeffrey Nolting
Jan 30, 2009·Schizophrenia Bulletin·Robert S KernStephen R Marder
Apr 24, 2009·Schizophrenia Bulletin·Jimmy ChoiAlice Medalia
Apr 27, 2010·Schizophrenia Bulletin·John Gerald Taylor
Dec 8, 2010·Schizophrenia Bulletin·Dawn I VelliganSanjay Dube
Sep 22, 2010·Australian Occupational Therapy Journal·Bhing-Leet Tan
Oct 1, 2011·Depression Research and Treatment·Boaz Levy, Emily Manove
Sep 1, 2012·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Masaaki TanakaYasuyoshi Watanabe
Nov 30, 2013·Schizophrenia Research and Treatment·Livia M M PontesHélio Elkis
Dec 22, 2009·Expert Review of Neurotherapeutics·S Kristian HillJohn A Sweeney
Jul 2, 2008·Expert Review of Neurotherapeutics·Caroline Demily, Nicolas Franck
Sep 13, 2012·Schizophrenia Research and Treatment·Marcelo ValenciaHector Ortega
Jun 19, 2012·Neuropharmacology·Britta HahnRobert W Buchanan
Dec 23, 2015·Trends in psychiatry and psychotherapy·Bruno Kluwe-SchiavonTárcio Soares
Jan 27, 2012·Human Psychopharmacology·Tomomi TenjinNoboru Yamaguchi
Jun 1, 2017·Asian Journal of Psychiatry·Ivana GoluzaNagesh Pai
Jun 23, 2007·Schizophrenia Research·E Serap MonkulDavid C Glahn
Dec 26, 2006·Expert Review of Neurotherapeutics·Daniel R Mueller, Volker Roder
Jul 6, 2007·Expert Review of Neurotherapeutics·Glenn D Shean
Apr 5, 2014·Qualitative Health Research·Wendy Gale Nordick, Kate van Heugten
Oct 19, 2012·The Australian and New Zealand Journal of Psychiatry·Stuart J LeeJayashri Kulkarni
Jan 18, 2012·The International Journal of Social Psychiatry·Bertilee BurgessRoger C Gibson
Jan 11, 2017·Applied Neuropsychology. Adult·Lasha CorbettMark Williams
Dec 16, 2017·Clinical EEG and Neuroscience·Kazuki Sueyoshi, Tomiki Sumiyoshi
Mar 25, 2016·The Journal of Nervous and Mental Disease·Aida FarrenyJudith Usall
Sep 1, 2011·The Journal of Nervous and Mental Disease·Alice M SapersteinMorris D Bell
Oct 9, 2007·Current Opinion in Psychiatry·Giovanni Stanghellini, Massimo Ballerini
Jan 1, 2009·Clinical Schizophrenia & Related Psychoses·Dinesh MittalDilip Jeste
Mar 6, 2010·Clinical Schizophrenia & Related Psychoses·Lora Humphrey BeebeO Dessieux

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Schizophrenia Bulletin
Elizabeth W TwamleyAlan S Bellack
Schizophrenia Bulletin
Steven M Silverstein, Sandra M Wilkniss
Neuropsychology Review
Alice Medalia, Jimmy Choi
The American Journal of Psychiatry
S R McGurkKim T Mueser
© 2022 Meta ULC. All rights reserved